StonvexLoading…
StonvexStonvexStonvexCore line items from ARW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $30.85B | $27.92B | $33.11B | $37.12B |
Operating Income | $822.22M | $768.56M | $1.47B | $2.07B |
Net Income | $571.27M | $392.07M | $903.50M | $1.43B |
EPS (Diluted) | $10.93 | $7.29 | $15.84 | $21.80 |
Total Assets | $29.08B | $21.76B | $21.73B | $21.76B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $306.47M | $188.81M | $218.05M | $176.91M |
Free Cash Flow OCF − CapEx | $-37.20M | $1.04B | $622.16M | $-111.91M |
Shares Outstanding | 52.26M | 53.80M | 57.03M | 65.45M |